News
![MOZOG NEURON](https://www.prolekare.cz/media/cache/resolve/article_list_item_large/media/image/11000048fce9a96bd4a1632b06e7a752.png)
Ocrelizumab in the Treatment of Multiple Sclerosis – 10-Year Data
Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current information on the long-term efficacy and safety of treatment is therefore absolutely essential for the optimal choice of therapeutic agent – in this case, ocrelizumab.
![symptomatická léčba](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/2d0246b60b0b53b98e4bb1476d4dfaab.jpg)
Long-term Efficacy and Safety of Mavacamten in the Treatment of Obstructive HCM
Interim results of the MAVA-LTE study provide the latest data on the long-term safety and efficacy…
![farmakoterapie](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/9bdb9a5dbe95a0c9e2bbc71529fac1fa.jpg)
Mavacamten in the Treatment of HCM in Patients Referred for Septal Reduction
Extended 56-week follow-up of patients with hypertrophic cardiomyopathy (HCM) resistant to current…
![starší muž aktivita](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/d27b99278cca2baf7148a678083caa05.jpg)
How Does Myelodysplastic Syndrome Affect Patients' Quality of Life?
Myelodysplastic syndrome (MDS) is a heterogeneous group of disorders of hematopoietic stem cells…
![3D tisk](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/d1456865c92bd8b2a42cbaf0a5d417e7.jpg)
Planning Surgery Using 3D Printing in Practice – Case Study
In October 2023, an article by neurosurgeons from Leipzig University was published in the journal …
![trombocyty](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/8e5c5558f8e3df1c08e397076669341a.jpg)
Immunomodulation and Romiplostim − What Does the Recently Published iROM Study Say?
Primary immune thrombocytopenia (ITP) is caused by an immunity disorder, involving not only the…
![klinickastudie](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/07dfbe2db796303f71f880cf7fd49698.jpg)
ICIS Report: Potential of TPO-RA as Early Immunomodulatory Treatment of Immune Thrombocytopenia
The report from the meeting of the Intercontinental Cooperative ITP Study Group (ICIS) in 2022 in…
![léčba leukemie_lékař a pacient](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/c59fc73ce3dfccf67fb5fe6ba43e7b00.jpg)
Impact of Azacitidine Maintenance Therapy on Survival of Patients with AML in Remission Depending on Initial Chemotherapy
The QUAZAR AML-001 study showed that oral azacitidine maintenance therapy significantly prolongs…
![docSova](https://www.prolekare.cz/media/cache/resolve/custom/rc/SyS0OuGI/media/image/72ff237332c5c6d0d06e6d9e4476e8ce.jpg?filters%5Bcrop%5D%5Bsize%5D%5B0%5D=835&filters%5Bcrop%5D%5Bsize%5D%5B1%5D=655&filters%5Bcrop%5D%5Bstart%5D%5B0%5D=8&filters%5Bcrop%5D%5Bstart%5D%5B1%5D=0&filters%5Bthumbnail%5D%5Bsize%5D%5B0%5D=140&filters%5Bthumbnail%5D%5Bsize%5D%5B1%5D=110&filters%5Bthumbnail%5D%5Bmode%5D=outbound&filters%5Bthumbnail%5D%5Ballow_upscale%5D=1)
Doc. Milan Sova: AAT substitution is available to all indicated patients. It is therefore crucial to now educate about the necessity of regular treatment
Alpha-1-antitrypsin deficiency (AATD) is one of the most common genetic disorders in adults. It is…
![kost_](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/bd68d132b2e9f5374e6122dbfe0cee0e.jpg)
Anabolic Antiosteoporotic Treatment as a First Step in Patients with Very High Fracture Risk
According to the 2022 opinion of the ESCEO (European Society for Clinical and Economic Aspects of…